Metformin / pioglitazone User Reviews & Ratings
Brand names: ActoPlus Met
Metformin / pioglitazone has an average rating of 6.8 out of 10 from a total of 5 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 25% reported a negative experience.
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Diabetes, Type 2 | 5 reviews for Diabetes, Type 2 | 153 medications |
- O H...
- November 25, 2009
ActoPlus Met (metformin / pioglitazone) for Diabetes, Type 2 "Very effective in controlling my blood sugars. I have had A1Cs of 6.0 and lower over the last 3 years taking 1500 mg/day. Recently, the company changed insurance, and I no longer have prescription coverage. At a cost of $350/month, I am looking for a generic version now."
- Anonymous
- November 20, 2010
ActoPlus Met (metformin / pioglitazone) for Diabetes, Type 2 "I have had bad reactions to metformin in the past but my doctor insisted on my trying Actosplus Met. After a few months I had the same bad reactions. Right now I'm struggling to keep my sugars under control."
- Anonymous
- June 1, 2009
ActoPlus Met (metformin / pioglitazone) for Diabetes, Type 2 "This has been effective in controlling my blood sugar, but I have a terrible problem trying to lose weight. I gained 20 pounds in less than 6 months."
- Anonymous
- March 30, 2009
ActoPlus Met (metformin / pioglitazone) for Diabetes, Type 2 "Fairly effective. Too expensive."
More about metformin / pioglitazone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiabetic combinations
- En español
Patient resources
- Metformin and pioglitazone drug information
- Pioglitazone and metformin (Advanced Reading)
- Pioglitazone and Metformin Tablets
ActoPlus Met (metformin / pioglitazone) for Diabetes, Type 2 "I have been taking ActoPlus Met 15/850 for Type 2 diabetes for approximately 3 years. My HbA1C has been steady between 6.0 and 6.3. If I'm having side effects, they are not noticeable. The price, however, must put a smile on the pharmaceutical company's CEO's face. It would be nice to see it go generic!"